Dansereau S, Cui H, Dartawan R, Sheng J
Genes (Basel). 2025; 16(1).
PMID: 39858595
PMC: 11765398.
DOI: 10.3390/genes16010048.
Quadiri A, Prakash S, Zayou L, Dhanushkodi N, Chilukuri A, Ryan G
Vaccines (Basel). 2025; 13(1).
PMID: 39852826
PMC: 11769137.
DOI: 10.3390/vaccines13010047.
Chentoufi A, Ulmer J, BenMohamed L
Vaccines (Basel). 2025; 13(1).
PMID: 39852809
PMC: 11769099.
DOI: 10.3390/vaccines13010030.
Lv K, Yu Z, Wang J, Li N, Wang A, Xue T
Adv Sci (Weinh). 2024; 11(45):e2404684.
PMID: 39387241
PMC: 11615764.
DOI: 10.1002/advs.202404684.
Liu Y, Huang Y, He G, Guo C, Dong J, Wu L
Int J Mol Sci. 2024; 25(18).
PMID: 39337651
PMC: 11432440.
DOI: 10.3390/ijms251810166.
Fatty aldehyde bisulfite adducts as a purification handle in ionizable lipid synthesis.
Atwood G, Purbiya S, Reid C, Smith B, Kaur K, Wicks D
RSC Adv. 2024; 14(36):26233-26238.
PMID: 39161429
PMC: 11332587.
DOI: 10.1039/d4ra05189k.
RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens.
Kola N, Patel D, Thakur A
Methods Mol Biol. 2024; 2813:321-370.
PMID: 38888787
DOI: 10.1007/978-1-0716-3890-3_21.
siRNA-mediated reduction of a circulating protein in swine using lipid nanoparticles.
Cau M, Ferraresso F, Seadler M, Badior K, Zhang Y, Ketelboeter L
Mol Ther Methods Clin Dev. 2024; 32(2):101258.
PMID: 38779336
PMC: 11109470.
DOI: 10.1016/j.omtm.2024.101258.
mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model.
De Pooter D, Pierson W, Pourshahian S, Dockx K, De Clerck B, Najera I
Vaccines (Basel). 2024; 12(3).
PMID: 38543871
PMC: 10976109.
DOI: 10.3390/vaccines12030237.
Dendritic Cell-Mimicking Nanoparticles Promote mRNA Delivery to Lymphoid Organs.
Cao Y, Long J, Sun H, Miao Y, Sang Y, Lu H
Adv Sci (Weinh). 2023; 10(33):e2302423.
PMID: 37867227
PMC: 10667832.
DOI: 10.1002/advs.202302423.
COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events.
Giannotta G, Murrone A, Giannotta N
Vaccines (Basel). 2023; 11(4).
PMID: 37112659
PMC: 10145134.
DOI: 10.3390/vaccines11040747.
Potential of siRNA in COVID-19 therapy: Emphasis on design and nanoparticles based delivery.
Fopase R, Panda C, Rajendran A, Uludag H, Pandey L
Front Bioeng Biotechnol. 2023; 11:1112755.
PMID: 36814718
PMC: 9939533.
DOI: 10.3389/fbioe.2023.1112755.
Application of lipid-based nanoparticles in cancer immunotherapy.
Zhang Z, Yao S, Hu Y, Zhao X, Lee R
Front Immunol. 2022; 13:967505.
PMID: 36003395
PMC: 9393708.
DOI: 10.3389/fimmu.2022.967505.
A Route to Lipid ALC-0315: a Key Component of a COVID-19 mRNA Vaccine.
Saadati F, Cammarone S, Ciufolini M
Chemistry. 2022; 28(48):e202200906.
PMID: 35665545
PMC: 9348069.
DOI: 10.1002/chem.202200906.